Condition: Dyslipidemias · Atherosclerosis · Diabetes Mellitus, Type 2 · Sponsor: Seoul National University Bundang Hospital
This is a randomized controlled study to assess the effect of atorvastatin and omega 3 combination therapy compared with atorvastatin and ezetimibe combination therapy in Korean T2DM patients with asymptomatic atherosclerosis.
This description comes directly from the study's public registry record.
Soo Lim · +82-31-787-7035 · limsoo@snu.ac.kr
Minji Sohn · rainbowmjs@naver.com
Always discuss trial participation with your own doctor first.
| SNUBH | Seongnam-si, Gyeonggi-do, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05365438